Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 48 Bortezomib 22 Lenalidomide 20 Cyclophosphamide 20 daratumumab 18 Calcium Dobesilate 15 Melphalan 13 Thalidomide 12 carfilzomib 9 pomalidomide 7 Prednisone 7 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Peripheral Blood Stem Cell Transplantation 6 Doxorubicin 6 isatuximab 5 Filgrastim 5 Vincristine 4 Interferon-alpha 3 Etoposide 3 selinexor 2 sargramostim 2 ixazomib 2 elotuzumab 2 cobimetinib 2 belantamab mafodotin 2 Steroids 2 Stem Cell Transplantation 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × darlin protein, Dictyostelium × Plasma cell × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡